NAGE - Niagen Bioscience, Inc.
Niagen Bioscience, Inc. Logo

NAGE - Niagen Bioscience, Inc.

https://www.niagenbioscience.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.

52W High
$14.69
52W Low
$3.16
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.95
Valuation
Rich
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
59.00
Forward P/E (<15 better)
65.36
EV/EBITDA (<8 favorable)
50.62
EV/Revenue (<3 favorable)
6.89
P/S (TTM) (<3 favorable)
7.75
P/B (<3 favorable)
14.37
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
34.44%
Institutions (25–75% balanced)
30.60%
Shares Outstanding
78,770,000
Float
51,793,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
107,925,000
Gross Profit (TTM)
67,461,000
EPS (TTM)
0.18
Profit Margin (>10% good)
0.13%
Operating Margin (TTM) (higher better)
0.16%
ROE (TTM) (>15% strong)
0.34%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.38
Momentum
Bearish momentum
Value
-0.1777
Previous
-0.1933
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025